ipilimumab
pharmaceutical drug
Facts
12 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound
- Has use
- medication[4]
- Active ingredient in
- Yervoy[16]
- Has characteristic
- biopharmaceutical[6]
- LiverTox likelihood score
- LiverTox toxicity likelihood category A[17]
- Medical condition treated
- metastatic melanoma, melanoma, renal cell carcinoma, myelodysplastic syndrome, non-small-cell lung carcinoma, skin cancer[7][8][9][10][11][12]
- Physically interacts with
- cytotoxic T-lymphocyte associated protein 4[3]
- Pregnancy category
- US pregnancy category C[15]
- Route of administration
- intravenous infusion and defusionههبهلخل[5]
- Subject has role
- monoclonal antibody[14]
- World Health Organisation international non-proprietary name
- ipilimumab[13]
🏷️ Also known as
en ipilimumab
en MDX-010
en MDX-101
en MDX-CTLA-4
en MOAB-CTLA-4
ar إيبيليموماب
fa ایپیلیموماب
he איפילימומאב
id MDX-010
id MDX-101
id MOAB-CTLA-4
id Yervoy
it Yervoy
it MDX-010
it MDX-101
ja イピリムマブ
ko 이필리무맙
pt Yervoy
ru Ервой
ru ипилимумаб
🔖 Identifiers · 19
- OpenAlex ID
- C2781433595
- ATC code
- L01XC11
- CAS Registry Number
- 477202-00-9
- ChEMBL ID
- CHEMBL1789844
- DeCS ID
- 57066
- DrugBank ID
- DB06186
- Encyclopædia Britannica Online ID
- science/ipilimumab
- Freebase ID
- /m/027ywgv
- Guide to Pharmacology Ligand ID
- 6888
- KEGG ID
- D04603
- LiverTox ID
- Ipilimumab
- MeSH descriptor ID
- D000074324
Show all 19 identifiers +7
- MeSH tree code
- D12.776.124.486.485.114.224.060.798, D12.776.124.790.651.114.224.060.798, D12.776.377.715.548.114.224.200.798
- MedlinePlus drug identifier
- a611023
- Microsoft Academic ID (discontinued)
- 2781433595
- NDF-RT ID
- N0000182641
- RxNorm CUI
- 1094833
- UNII
- 6T8C155666
- WikiProjectMed ID
- Ipilimumab
🔗 Connections
← Drug or therapy used for treatment 6
Medical condition treated 5
Has characteristic 1
Has use 1
Physically interacts with 1
Route of administration 1
Subclass of 1
Subject has role 1
← Physically interacts with 1
Press Enter · cited answer in seconds